Stapokibart injection

BIOLOGICAL3 trials

Sponsors

Keymed Biosciences Co.Ltd, Chengdu Kangnuoxing Biopharma,Inc.

Conditions

Allergic RhinitisBullous Pemphigoid (BP)Seasonal Allergic Rhinitis (SAR)

Phase 2

Study of Stapokibart Injection in Patients With Allergic Rhinitis

RecruitingNCT06525597

Keymed Biosciences Co.LtdAllergic Rhinitis

Start: 2024-09-30End: 2025-10-30Target: 120Updated: 2024-11-08

Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Not yet recruitingNCT07617324

Chengdu Kangnuoxing Biopharma,Inc.Seasonal Allergic Rhinitis (SAR)

Start: 2026-06-01End: 2027-02-01Target: 15Updated: 2026-06-01

Phase 3

Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid

Not yet recruitingNCT07210554

Chengdu Kangnuoxing Biopharma,Inc.Bullous Pemphigoid (BP)

Start: 2025-11-11End: 2028-05-08Target: 200Updated: 2025-10-07